Disruption of this central regulatory system, including alterations in TRH, CRH, and GnRH secretion, provides a mechanistic explanation for the broader physiological consequences of mycotoxin exposure (177), such as growth retardation, reproductive disorders, and appetite dysregulation (178180)
Retatrutide is the first and only triple receptor agonist to reach Phase 3 clinical trials
Over the last few years, the popularity of taking GLP-1 medications for weight loss has greatly increased
At Ageless Center, our integrative health approach evaluates the full metabolic picture, because weight loss, hormonal balance, and sexual health are not separate clinical tracks